Jim Simons Dare Bioscience, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 762,900 shares of DARE stock, worth $312,789. This represents 0.0% of its overall portfolio holdings.
Number of Shares
762,900
Previous 719,400
6.05%
Holding current value
$312,789
Previous $222,000
68.47%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding DARE
# of Institutions
37Shares Held
6.86MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.45MShares$1.41 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA989KShares$405,6160.0% of portfolio
-
Black Rock Inc. New York, NY396KShares$162,4000.0% of portfolio
-
State Street Corp Boston, MA248KShares$101,5610.0% of portfolio
-
Northern Trust Corp Chicago, IL183KShares$75,1530.0% of portfolio
About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $34.8M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...